Dr Aamir Jalil, PhD is an expert in Pharmacy at Universität Innsbruck (Austria). Aamir Jalil has authored 49 publications, the most recent in 2025. SLR score: 113 (community average: 125). How the SLR is computed.

LeadR Profile

Dr Aamir Jalil, PhD Universität Innsbruck Austria
113 ScienceLeadR Reputation 113
Network Map

Pharmacy

Subspecialties: Dermatology - Infectiology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2015 - 2025

Source: PubMed

Universität Innsbruck

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 49

Citations

Citations: 1 178 1st author: 10 Last author: 2 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Colistin adorned topical nanoemulsion gel formulation for enhanced anti-microbial activity.
PMID 41028143 — skin, colistin, pharmaceutical preparations, natural science disciplines, therapeutics, drug liberation, bacteria, infections
Sci Rep20250
Corrigendum to "S-protected thiolated hyaluronic acid: In-situ crosslinking hydrogels for 3D T cell culture scaffold" [Carbohydrate Polymers 237 (2020) 116092].
PMID 40912817 — cells, hydrogels, polymers, hyaluronic acid, polysaccharides, carbohydrates, t-lymphocytes, cell culture techniques
Carbohydr Polym20250
Lipid-Based Nanocarriers for Topical Therapy of Cutaneous Leishmaniasis: An Insight into the Mechanism of Action.
PMID 40547705 — skin, nanoparticles, pharmaceutical preparations, leishmaniasis, cutaneous, therapeutics, leishmaniasis
ACS Omega20250
Formation of self-assembled polyelectrolyte complex derived from BSA and nanogels: a study to optimize processing parameters and preserve protein integrity.
PMID 40103400 — nanogels, drug industry, technology, pharmaceutical, esterases, polyelectrolytes
Drug Dev Ind Pharm20250
Correction: Habib et al. Thiolated Chitosan Microneedle Patch of Levosulpiride from Fabrication, Characterization to Bioavailability Enhancement Approach. 2022, , 415.
PMID 39684194 — biological availability, chitosan, microneedle drug delivery
Polymers (Basel)20241

LeadR Networks

Main global connection map